Justin Miller

Justin Miller is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as a Product Portfolio Analyst at Telix Pharmaceuticals Limited since April 2022. Previously, Justin held significant roles including Director of New Product Planning at Clarametyx Biosciences, where focus was on developing targeted therapies for serious infections, and Consulting Director of Commercial Product Strategy at Armatus Bio, Inc., which is advancing innovative gene therapy candidates. Justin co-founded Quorum Therapeutics, leading it as CEO to develop non-antibiotic treatments for bacterial infections, and was also a Co-Founder and Chief Business Officer at Qrumpharma Inc., which developed novel therapies for cystic fibrosis-related infections. Earlier experience includes senior marketing roles at Kinnear Pharmaceuticals and commercialization analysis at The Ohio State University's TEC Institute. Justin holds an MBA with a concentration in Finance and a Bachelor of Arts in Economics from The Ohio State University, along with an International Baccalaureate diploma from the American International School Vienna.